Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: Prepared on behalf of the British Committee for Standards in Haematology by a Working Party of the Haemato-Oncology Task Force

British Journal of Haematology

Volumn 155, Issue 3, 2011, Pages 308-317

  Davies, John M ^a   Lewis, Michael P N ^b   Wimperis, Jennie ^b   Rafi, Imran ^c   Ladhani, Shamez ^d   Bolton Maggs, Paula H B ^e  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

General haematology; Infection; Splenectomy

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE PLUS MENINGOCOCCAL GROUP C VACCINE; MENINGOCOCCUS VACCINE; MENITORIX; PEDIACEL; PENICILLIN G; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBODY RESPONSE; ASPLENIA; DRUG CHOICE; DRUG INDICATION; HEMATOLOGIC MALIGNANCY; HEMATOLOGY; HIGH RISK PATIENT; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFLUENZA VACCINATION; LONG TERM CARE; MEDICAL INFORMATION; MEDICAL SOCIETY; MENINGOCOCCEMIA; MENINGOCOCCOSIS; ONCOLOGY; PATIENT COUNSELING; PATIENT EDUCATION; PNEUMOCOCCAL INFECTION; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING TEST; SEPSIS; SICKLE CELL ANEMIA; SPLEEN DISEASE; SPLENECTOMY; VACCINATION; VACCINE FAILURE;

ADOLESCENT; ADULT; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; SPLENECTOMY; SPLENIC DISEASES; YOUNG ADULT;

EID: 80053966871     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08843.x     Document Type: Review

References (46)

1. Adamkiewicz, T.V., Silk, B.J., Howgate, J., Baughman, W., Srayhorn, G., Sullivan, K. & Farley, M.M. (2008) Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Paediatrics, 121, 562-569.
2. Balmer, P., Borrow, R. & Arkwright, P.D. (2007a) The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccine. Vaccine, 25, 6321-6325.
3. Balmer, P., Cant, A.J. & Borrow, R. (2007b) Anti-pneumococcal antibody titre measurement: what useful information does it yield? Journal of Clinical Pathology, 60, 345-350.
4. British Committee for Standards in Haematology (1996) Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. British Medical Journal, 312, 430-434.
5. Cherif, H., Landgren, O., Konradsen, H.B., Kalin, M. & Bjorkholm, M. (2006) Poor antibody response to polysaccharide pneumococcal vaccination suggests increased susceptibility to pneumococcal infection in splenectomised patients with haematological diseases. Vaccine, 24, 75-81.
6. Corazza, G.R., Ginaldi, L., Zoli, G., Frisoni, M., Lalli, G., Gasbarrini, G. & Quaglino, D. (1990) Howell-Jolly body counting as a measure of splenic function. A reassessment. Clinical and Laboratory Haematology, 12, 269-275.
7. Cummins, D., Heuschkel, R. & Davies, S.C. (1991) Penicillin prophylaxis in children with sickle cell disease in Brent. British Medical Journal, 302, 989-990.
8. Cuthbert, R.J., Iqbal, A., Gares, A., Toghill, P.J. & Russell, N.H. (1995) Functional hyposplenism following allogeneic bone marrow transplantation. Journal of Clinical Pathology, 48, 257-259.
9. Davies, J.M., Barnes, R. & Milligan, M. (2002) Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clinical Medicine, 5, 440-443.
10. De Porto, A.P.N.A., Lammers, A.J.J., Bennink, R.J., ten Berge, I.J.M., Speelman, P. & Hoekstra, J.B.L. (2010) Assessment of splenic function. European Journal of Clinical Microbiology and Infectious Disease, 29, 1465-1473.
11. De roux, A., Schmole-Thoma, B., Siber, G.R., Hackell, J.G., Kuhnke, A., Ahlers, N., Baker, S.A., Razmpour, A., Emini, E.A., Fernsten, P.D., Gruber, W.C., Lockhart, S., Burkhardt, O., Welte, T. & Lode, M. (2008) Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clinical Infectious Disease, 46, 1015-1023.
12. Department of Health (2010) Immunisation Against Infectious Disease (The Green Book). HMSO, London. Available at: Accessed on 09 September 2011.
13. Deshmukh, P.M., Camp, C.J., Rose, F.B. & Narayanan, S. (2004) Capnocytophaga canimorsus sepsis with purpura fulminans and symmetrical gangrene following a dog bite in a shelter employee. American Journal of medical Science, 327, 369-372.
14. Eber, S.W., Langendorfer, C.M., Ditzig, M., Reinhardt, D., Stohr, G., Soldan, W., Schroter, W. & Tchernia, G. (1999) Frequency of very late sepsis after splenectomy for heriditary spherocytosis: impact of insufficient antibody response to pneumococcal infection. Annals of Haematology, 78, 524-528.
15. Engelhard, D., Cordonnier, C., Shaw, P.J., Parkalli, T., Guenther, C., Martino, R., Dekker, A.W., Prentice, H.G., Gustavsson, A., Nurnberger, W. & Ljungman, P. (2002) (IDWP-EBMT) Early and late invasive pneumococcal infection following stem cell transplantation: a European bone marrow transplantation survey. British Journal of Haematology, 117, 444-450.
16. Falletta, J.M., Woods, G.M., Verter, J.I., Buchanan, G.R., Pegelow, C.H., Iyer, R.V., Miller, S.T., Holbrook, C.T., Kinney, T.R. & Vichinsky, E. (1995) Discontinuing penicillin prophylaxis in children with sickle cell anaemia. Prophylactic study II. Journal of Paediatrics, 127, 685-690.
17. Hicks, L.A., Harrison, L.H., Flannery, B., Hadler, J.L., Schaffner, W., Craig, A.S., Jackson, D., Thomas, A., Beall, B., Lynfield, R., Reingold, A., Farley, M.M. & Whitney, C.G. (2007) Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. Journal of Infectious Diseases, 196, 1346-1354.
18. Keenan, R.D., Boswell, T. & Milligan, D.W. (1999) Do post-splenectomy patients take prophylactic penicillin? British Journal of Haematology, 105, 509-510.
19. Kulkharni, S., Powles, R., Treleaven, J., Riley, U., Singhal, S., Horton, C., Sirohi, B., Bhagwati, N., Meller, S., Saso, R. & Mehta, J. (2000) Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood, 95, 3683-3686.
20. Kyaw, M.H., Holmes, E.M., Toolis, F., Wayne, B., Chalmers, J., Jones, I.G. & Campbell, H. (2006) Evaluation of severe infection and survival after splenectomy. American Journal of Medicine, 119, 276 1-7.
21. Lammers, A.J., Veninga, D., Lombarts, M.J., Hoekstra, J.B. & Speelman, P. (2010) Management of post-splenectomy patients in the Netherlands. European Journal of Clinical Microbial Infectious Diseases, 29, 399-405.
22. Landgren, O., Bjorkholm, M., Konradsen, H.B., Soderqvist, M., Nilsson, B., Gustavsson, A., Axdorph, U., Kalin, M. & Grimfors, G. (2004) A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomised individuals with special reference to Hodgkin's lymphoma. Journal of Internal Medicine, 255, 664-673.
23. Lin, P.L., Michaels, M.G., Green, M., Mazariegos, G.V., Webber, S.A., Lawrence, K.S., Iurlano, K. & Greenberg, D.P. (2005) Safety and immunogenicity of the American Academy of Paediatrics-recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in paediatric solid organ recipients. Paediatrics, 116, 160-167.
24. Ludvigsson, J.F., Olen, O., Bell, M., Ekbom, A. & Montgomery, S.M. (2008) Coeliac disease and risk of sepsis. Gut, 57, 1074-1080.
25. Malangoni, M.A., Dillon, L.D., Klamer, T.W. & Condon, R.L. (1984) Factors influencing the risk of early and late serious infection in adults after splenectomy for trauma. Surgery, 96, 775-783.
26. Meerveld-Eggink, A., de Weerdt, O., Rijkers, G.T., van Velzen-Blad, H. & Biesma, D.H. (2008) Vaccination awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands. Vaccine, 26, 6975-6979.
27. Musher, D.M., Ceasar, H., Kojic, E.M., Musher, B.L., Gathe, J.C., Romero- Steiner, S. & White, A.C. (2005) Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine. Journal of Infectious Diseases, 191, 1063-1067.
28. Oniyangi, O. & Omari, A.A. (2006) Malaria chemoprophylaxis in sickle cell disease. Cochrane Database Systematic Review, Issue 4, CD003489.
29. Orthopoulos, G.V., Theodoridou, M.C., Ladis, V.A., Tsousis, D.K. & Spoulou, V.I. (2009) The effect of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic subjects with beta-thalassemia. Vaccine, 27, 350-354.
30. Pao, M., Papadopoulos, E.B., Chou, J., Glenn, H., Castro-Malaspina, H., Jakubowski, A.A., Kernan, N.A., Perales, M.A., Prokop, S., Scaradavou, A., Van Den Brink, M.R., Young, J.W., O'Reilly, R.J. & Small, T.N. (2008) Response to pneumococcal (PNCRM7) and Haemophilus influenzae conjugate vaccines (HIB) in paediatric and adult recipients of an allogeneic hematopoietic stem cell transplantation (alloHCT). Biology of Blood and Marrow Transplantation, 14, 1022-1030.
31. Picardi, M., Selleri, C. & Rotoli, B. (1999) Spleen size by ultrasound and risk of pneumococcal infection in patients with chronic GVDD: preliminary observations. Bone Marrow Transplantation, 24, 173-177.
32. Reinert, P., Benkerrou, M., de Montalembert, M., Lesprit, E., Abadie, I., Bernaudin, F., Doit, C., Bingen, E., Tetelboum, R. & Bonnet, E. (2007) Immunogenicity of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease. Paediatric Infectious Diseases Journal, 26, 1105-1109.
33. Riddington, C. & Owusu-Ofori, S. (2002) Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database Systematic Review, Issue 3, CD003427.
34. Rose, M.A., Schubert, R., Strnad, N. & Zielen, S. (2005) Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine. Clinical Diagnostic Laboratory Immunology, 12, 1216-1222.
35. Shatz, D.V., Schinskey, M.F., Pais, L.B., Romero-Steiner, S., Kirton, O.C. & Carlone, G.M. (1998) Immune responses of splenectomised trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14days after splenectomy. The Journal of Trauma, Injury, Infection and Critical Care, 44, 760-765.
36. Shetty, N., Aurora, P. & Ridgway, G.L. (1998) A failure of anti-pneumococcal vaccine and prophylactic penicillin in the splenectomised patient. Journal of Infection, 37, 87-88.
37. Singleton, R.J., Hennessy, T.W., Bulkow, L.R., Hammitt, L.L., Zulz, T., Hurlburt, D.A., Butler, J.C., Rudolph, K. & Parkinson, A. (2007) Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal vaccine coverage. Journal of the American Medical Association, 297, 1784-1792.
38. Smets, F., Bourgois, A., Vermylen, C., Brichard, B., Slacmuylders, P., Leyman, S. & Sokal, E. (2007) Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine. Vaccine, 25, 5278-5282.
39. Snape, M.D., Perrett, K.P. & Ford, K.J. (2008) Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants; a randomised controlled trial. Journal of the American Medical association, 299, 173-184.
40. Spickett, G.P., Bullimore, J., Wallis, J., Smith, S. & Saunders, P. (1999) Northern Region asplenia register analysis of first two years. Journal of Clinical Pathology, 52, 424-429.
41. Stanford, E., Print, F., Falconer, M., Lamden, K., Ghebrehewet, S., Phin, N., Baxter, D., Helbert, M., McCann, R., Andrews, N., Balmer, P., Borrow, R. & Kaczmarski, E. (2009) Immune response to pneumococcal conjugate vaccine in asplenic individuals. Human Vaccination, 5, 85-91.
42. Thomas, H.J., Wotton, C.J., Yeates, D., Ahmad, T., Jewell, D.P. & Goldacre, M.J. (2008) Pneumococcal infection in patients with celiac disease. European Journal of Gastroenterology and Hepatology, 20, 624-628.
43. Vila-Corcoles, A., Salsench, E., Rodriguez-Blanco, T., Ochoa-Gondar, O., De Diego, C., Valdivieso, A., Hospital, I., Gomez-Bertomeu, F. & Raga, X. (2009) Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study. Vaccine, 27, 1504-1510.
44. William, B.M. & Corazza, G.R. (2007) Hyposplenism: a comprehensive review. Part 1: basic concepts and causes. Haematology, 12, 1-13.
45. William, B.M., Thawani, N., Sae-Tia, S. & Corazza, G.R. (2007) Hyposplenism: a comprehensive review. Part II: clinical manifestations, diagnosis and treatment. Haematology, 12, 89-98.
46. Woolley, I., Jones, P., Spelman, D. & Gold, L. (2006) Cost-effectiveness of a post-splenectomy registry for prevention of sepsis in the asplenic. Australian and New Zealand Journal of Public Health, 30, 558-561.